DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Jeong YH, Kim IS, Park Y. et al.
Carriage of cytochrome 2C19 polymorphism is associated with risk of high post-treatment platelet reactivity on high maintenance-dose clopidogrel of 150 mg/day: results of the ACCEL-DOUBLE (Accelerated Platelet Inhibition by a Double Dose of Clopidogrel According to Gene Polymorphism) study.
J Am Coll Cardiol Intv 2010;
3: 731-741.
Access:
We do not assume any responsibility for the contents of the web pages of other providers.